Clinical studies of alpha-interferons in chronic myelogenous leukemia

M Talpaz¹

Affiliations

Review

M Talpaz. Cancer Treat Rev. 1988 Jan.

. 1988 Jan:15 Suppl A:49-53.

doi: 10.1016/0305-7372(88)90074-6.

M Talpaz¹

¹ Department of Clinical Immunology and Biological Therapy, M.D. Anderson Hospital and Tumor Institute, Houston, Texas.

No abstract available

Similar articles

Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Alimena G, Morra E, Lazzarino M, Liberati AM, Montefusco E, Inveradi D, Bernasconi P, Mancini M, Grignani F, Bernasconi C, et al. Alimena G, et al. Cancer Treat Rev. 1988 Jan;15 Suppl A:21-6. doi: 10.1016/0305-7372(88)90070-9. Cancer Treat Rev. 1988. PMID: 3277708 Clinical Trial. No abstract available.
The activity of alpha interferons in chronic myelogenous leukemia.
Talpaz M. Talpaz M. Am J Med Sci. 1988 Aug;296(2):95-7. doi: 10.1097/00000441-198808000-00003. Am J Med Sci. 1988. PMID: 3165249 No abstract available.
Management of chronic myelogenous leukemia.
Griffin JD. Griffin JD. Semin Hematol. 1986 Jul;23(3 Suppl 1):20-6. Semin Hematol. 1986. PMID: 3526559 Review. No abstract available.
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU. Talpaz M, et al. N Engl J Med. 1986 Apr 24;314(17):1065-9. doi: 10.1056/NEJM198604243141701. N Engl J Med. 1986. PMID: 3457264
Chronic myeloid leukemia.
Silver RT, Gale RP. Silver RT, et al. Am J Med. 1986 Jun;80(6):1137-48. doi: 10.1016/0002-9343(86)90676-5. Am J Med. 1986. PMID: 3524211 Review. No abstract available.